Last checked at 24 Apr 2019 12:44
Wednesday broker round-up
(Sharecast News) - Saga: JP Morgan upgrades to neutral with a target price of 80p.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,780.50
Bid:
1,773.00
Ask:
1,790.00
Change:
0.00 (0.00%)
Spread:
17.00 (0.959%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,780.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 Apr 2019 10:48
Silence Therapeutics Interim Finance Chief Quinn Appointed Permanently
LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will
Read more17 Apr 2019 08:22
Persimmon Appoints Glaxo VP As Independent Non-Executive Director
LONDON (Alliance News) - Persimmon PLC on Wednesday said it appointed Claire Thomas as independent non-executive director with effect from August 1.Thomas has been senior vice president at
Read more9 Apr 2019 07:29
GSK gets US green light for two-drug HIV treatment
(Sharecast News) - GlaxoSmithkline said its two drug HIV treatment had been granted US market approval.
Read more9 Apr 2019 06:58
GlaxoSmithKline Notes Approval Of HIV Drug Dovato In US
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said Dovato has been approved in the US as a treatment for HIV-1 infection in adults who have not previously been treated with antiretroviral
Read more5 Apr 2019 12:53
Friday broker round-up
(Sharecast News) - Purplebricks: Berenberg downgrades to sell with a target price of 80p.
Read more3 Apr 2019 11:59
GlaxoSmithKline's Juluca Suppresses HIV For Three Years In Studies
LONDON (Alliance News) - Drug major GlaxoSmithKline PLC on Wednesday noted that HIV treatment Juluca had been shown to maintain its suppression of the virus in patients after three is a two-drug a
Read more25 Mar 2019 17:14
DIRECTOR DEALINGS: Glaxo Senior Vice President Hirons Sells Shares
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said that Senior Vice President for global ethics and compliance Nick Hirons sold around GBP350,000 in shares.Hirons sold 22,178 on at
Read more21 Mar 2019 17:26
GlaxoSmithKline's Blood Cancer Drug Dreamm-1 Study Results Positive
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday it received "further positive" data from its Dreamm-1 study of patients with relapsed multiple myeloma.Multiple myeloma
Read more19 Mar 2019 18:24
TOP NEWS: GSK Gets Positive Result From Early Dostarlimab Cancer Study
LONDON (Alliance News) - GlaxoSmithKline PLC on Tuesday said data from the early-stage Garnet clinical study had promising results for the use of Dostarlimab in patients with endometrial was by by
Read more19 Mar 2019 13:15
Crossword Hires Advisory Board Chaired By Former Glaxo Security Head
LONDON (Alliance News) - Crossword Cybersecurity PLC on Tuesday said it has appointed a new advisory board that will be chaired by the former chief information security officer of GlaxoSmithKline
Read more8 Mar 2019 10:50
WINNERS & LOSERS SUMMARY: GVC Down 18% As Chiefs Sell 3 Million Shares
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 1.7%. The Mexican gold miner was tracking
Read more8 Mar 2019 07:47
TOP NEWS: GlaxoSmithKline Notes Positive Results From Two HIV Studies
LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said the Atlas and Flair studies showed that along-acting, injectable two-drug regimen in HIV-1 patients had similar efficacy to a daily a
Read more8 Mar 2019 07:39
LONDON MARKET PRE-OPEN: RPC Chooses Berry Offer Over Apollo
LONDON (Alliance News) - Stock prices in London are set for a lower open after disappointing Chinese economic data, while in early corporate news RPC has agreed a new takeover deal. China's in
Read more8 Mar 2019 07:17
GSK monthly HIV treatment meets targets
(Sharecast News) - Two late-stage clinical trials by GlaxoSmithKline's ViiV Healthcare joint venture of its novel, investigational, long-acting HIV treatment have both met their primary aims.
Read more